Hearing, balance and connection—all easy to take for granted, but profoundly impactful when disrupted. Disorders of the ear are often associated with feelings of frustration, decreased social interaction and depression. At Otonomy, our focus is on making new treatments a reality for the millions living with the debilitating, daily impact of these conditions. See Our Approach »
otonomy.com was registered 1 decade 7 years ago. It has a alexa rank of #1,074,134 in the world. It is a domain having .com extension. It is estimated worth of $ 1,200.00 and have a daily income of around $ 5.00. As no active threats were reported recently, otonomy.com is SAFE to browse.
Daily Unique Visitors: | 816 |
Daily Pageviews: | 1,632 |
Income Per Day: | $ 5.00 |
Estimated Worth: | $ 1,200.00 |
Google Indexed Pages: | Not Applicable |
Yahoo Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Google Backlinks: | Not Applicable |
Bing Backlinks: | Not Applicable |
Alexa BackLinks: | Not Applicable |
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: | Very Poor |
WOT Privacy: | Very Poor |
WOT Child Safety: | Very Poor |
Alexa Rank: | 1,074,134 |
PageSpeed Score: | 89 ON 100 |
Domain Authority: | 49 ON 100 |
Bounce Rate: | Not Applicable |
Time On Site: | Not Applicable |
Otonomy is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics to address diseases of the inner and ...
Otonomy Inc (NASDAQ: OTIC) may have hit a snag with the development of its lead ear disorder candidate Otividex. Still, the company is trumpeting an early win ...
Otonomy Reports First Quarter 2021 Financial Results. 5 months ago. Otonomy Announces Top-Line Results For The Phase 3 Clinical Trial Of Otividex® In ...
Information on stock, financials, earnings, subsidiaries, investors, and executives for Otonomy. Use the PitchBook Platform to explore the full profile.
Security and exchange commission filings for Otonomy, Inc.. Insider trades, quarterly, and annual reports.
May 11, 2021 ... Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the ...
View Otonomy (www.otonomy.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as ...
Affiliation. 1 Otonomy Inc., San Diego, California 92121, USA. [email protected] . PMID: 21099726; DOI: 10.1097/MAO.0b013e3182009d29 ...
Otonomy, Inc. operates as a biotechnology company. The Company develops therapeutics for treatment of inner and middle ear disorders. Otonomy serves ...
Latest News · Otonomy Announces FDA Approval of Otiprio (ciprofloxacin otic suspension) for Acute Otitis Externa - March 2, 2018 · FDA Approves Otiprio ( ...
Hearing, balance and connection—all easy to take for granted, but profoundly impactful when disrupted. Disorders of the ear are often associated with feelings ...
Otonomy Inc. $2.17. OTIC. After Hours: $2.18. ( 0.46%)+$0.0100. Closed: Jul 9, 5: 34:52 PM GMT-4 · USD · NASDAQ · Disclaimer. 1D. 5D. 1M. 6M. YTD. 1Y. 5Y.
Otonomy has 49 employees at their 1 location and $273 K in annual revenue in FY 2020. See insights on Otonomy including office locations, competitors, ...
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company ...
Otonomy's top competitors include MEI Pharma, Cadence Pharmaceuticals and Innocoll. See the full list of Otonomy competitors, plus revenue, employees, and ...
See what employees say it's like to work at Otonomy . Salaries, reviews, and more - all posted by employees working at Otonomy .
Jun 15, 2021 ... D., president and CEO of Otonomy. "We are pleased to initiate this expansion study in order to demonstrate the treatment benefit in a larger cohort ...
Feb 22, 2021 ... A phase 3 clinical trial of Otonomy's Otividex in inner ear condition Ménière's disease has missed its primary endpoint. The setback comes ...
Jan 27, 2020 ... Helping patients like Jay has been the driving force behind Otonomy, a company heading into a transformative 2020 with three clinical trial ...
Real time Otonomy (OTIC) stock price quote, stock graph, news & analysis.
Otonomy is a biopharmaceutical company dedicated to the development of therapeutics for diseases and disorders of the ear. The company offers the ...
OTONOMY, INC. (OTIC) IPO - NASDAQ.com.
H1 Headings: | 1 | H2 Headings: | 2 |
H3 Headings: | 1 | H4 Headings: | Not Applicable |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | 1 | Total Images: | 7 |
Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
living with | 2 | 0.73 % | No |
with the | 2 | 0.73 % | No |
millions living | 2 | 0.73 % | No |
the millions | 2 | 0.73 % | No |
new treatments | 2 | 0.73 % | No |
the debilitating | 2 | 0.73 % | No |
May Otonomy | 2 | 0.73 % | No |
David A | 1 | 0.365 % | No |
loss” David | 1 | 0.365 % | No |
hearing loss” | 1 | 0.365 % | No |
chief executive | 1 | 0.365 % | No |
A Weber | 1 | 0.365 % | No |
Weber Ph | 1 | 0.365 % | No |
executive officer | 1 | 0.365 % | No |
president and | 1 | 0.365 % | No |
and chief | 1 | 0.365 % | No |
Ph D | 1 | 0.365 % | No |
D president | 1 | 0.365 % | No |
Otonomy Discover | 1 | 0.365 % | No |
Initiates Expansion | 1 | 0.365 % | No |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
living with the debilitating | 2 | 0.73 % | No |
the millions living with | 2 | 0.73 % | No |
millions living with the | 2 | 0.73 % | No |
D president and chief | 1 | 0.365 % | No |
president and chief executive | 1 | 0.365 % | No |
and chief executive officer | 1 | 0.365 % | No |
chief executive officer Otonomy | 1 | 0.365 % | No |
Ph D president and | 1 | 0.365 % | No |
Weber Ph D president | 1 | 0.365 % | No |
and hearing loss” David | 1 | 0.365 % | No |
disease and hearing loss” | 1 | 0.365 % | No |
Ménière’s disease and hearing | 1 | 0.365 % | No |
hearing loss” David A | 1 | 0.365 % | No |
loss” David A Weber | 1 | 0.365 % | No |
A Weber Ph D | 1 | 0.365 % | No |
David A Weber Ph | 1 | 0.365 % | No |
executive officer Otonomy Discover | 1 | 0.365 % | No |
officer Otonomy Discover our | 1 | 0.365 % | No |
Expansion of Phase 12 | 1 | 0.365 % | No |
Initiates Expansion of Phase | 1 | 0.365 % | No |
Prepare for your calling at Faith Baptist Bible College & Theological Seminary. Regionally-accredited college, seminary, and online degrees.
Domain Registrar: | GoDaddy.com, LLC |
---|---|
Registration Date: | 2007-01-20 1 decade 7 years 9 months ago |
Last Modified: | 2020-05-25 4 years 5 months 3 weeks ago |
Host | IP Address | Country | |
---|---|---|---|
ns71.domaincontrol.com | 97.74.105.46 | United States | |
ns72.domaincontrol.com | 173.201.73.46 | United States |
Host | Type | TTL | Extra |
---|---|---|---|
otonomy.com | A | 593 |
IP: 35.231.139.107 |
otonomy.com | NS | 3600 |
Target: ns71.domaincontrol.com |
otonomy.com | NS | 3600 |
Target: ns72.domaincontrol.com |
otonomy.com | SOA | 3600 |
MNAME: ns71.domaincontrol.com RNAME: dns.jomax.net Serial: 2021012300 Refresh: 28800 Retry: 7200 Expire: 604800 |
otonomy.com | MX | 3600 |
Priority: 10 Target: us-smtp-inbound-1.mimecast.com |
otonomy.com | MX | 3600 |
Priority: 10 Target: us-smtp-inbound-2.mimecast.com |
otonomy.com | TXT | 3600 |
TXT: v=spf1 include:us._netblocks.mimecast.com include:spf.protection.outlook.com ip4:184.183.97.240 -all |
Koh Similan is concluding of the national park of the Similan Islands located in southern Thailand, 50 kilometers west of Khao Lak. It is considered the best place in Thailand...
Petsonic, l’animalerie en ligne qui vous propose une large gamme de produits de qualité d’alimentation et d’accessoires pour chiens et pour chats aux meilleurs prix.
Blog of Himanshu Sheth on Technology, Entrepreneurship and Business
Los Angeles Apparel is a manufacturer, designer and distributor of the clothing based in South-Central Los Angeles. The company was founded in 2016 by Dov Charney.